Lewis talks with Jonathan Tobin, a venture capitalist specialising in biotechnology investments. They talk about science, investment, and how new drugs get to market.
Lewis talks with Jonathan Tobin, a venture capitalist specialising in biotechnology investments. They talk about science, investment, and how new drugs get to market.